Turnstone Biologics (TSBX) Institutional Ownership → READ THIS – If You Missed Out On The AI Boom (From Banyan Hill Publishing) (Ad) Free TSBX Stock Alerts $2.66 -0.10 (-3.62%) (As of 04/29/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Turnstone Biologics (NASDAQ:TSBX)CurrentInstitutional OwnershipPercentage52.51%Number ofInstitutional Buyers(last 12 months)6TotalInstitutional Inflows(last 12 months)$16.20MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$2.35M Get TSBX Insider Trade Alerts Want to know when executives and insiders are buying or selling Turnstone Biologics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TSBX Institutional Buying and Selling by Quarter Ad Banyan Hill PublishingNvidia CEO Says It Will Be “the Next Revolution” Beyond AINvidia’s CEO calls it the “next amazing revolution” … and even declared it “is going to be flat out of the biggest [revolution] ever.” Jeff Bezos, Bill Gates, and Mark Zuckerberg have invested billions in it.Click on Adam's shiny forehead for more details. Turnstone Biologics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/17/2024 Kathleen S. Wright Associates Inc.42,553$111K0.1%N/A0.184% 2/15/2024PFM Health Sciences LP633,313$1.61M0.1%-58.5%2.742% 2/15/2024 Caas Capital Management LP45,831$117K0.0%-40.1%0.198% 12/6/2023Citigroup Inc.7,524$30K0.0%N/A0.033% 11/15/2023Sectoral Asset Management Inc.517,648$2.04M0.4%N/A2.266% 11/14/2023Eventide Asset Management LLC708,317$2.79M0.1%N/A3.101% 11/13/2023FMR LLC2,830,284$11.15M0.0%N/A12.392% 11/7/2023New York State Common Retirement Fund18,867$74K0.0%N/A0.083% (Data available from 1/1/2016 forward) TSBX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TSBX shares? During the previous two years, the following institutional investors and hedge funds held shares of Turnstone Biologics shares: FMR LLC ($11.15M), Eventide Asset Management LLC ($2.79M), Sectoral Asset Management Inc. ($2.04M), PFM Health Sciences LP ($1.61M), Caas Capital Management LP ($117K), Kathleen S. Wright Associates Inc. ($111K), and New York State Common Retirement Fund ($74K).Learn more on TSBX's institutional investors. What percentage of Turnstone Biologics stock is owned by institutional investors? 52.51% of Turnstone Biologics stock is owned by institutional investors. Learn more on TSBX's institutional investor holdings. Which institutional investors have been buying Turnstone Biologics stock? The following institutional investors have purchased Turnstone Biologics stock in the last 24 months: FMR LLC ($2.83M), Eventide Asset Management LLC ($708.32K), Sectoral Asset Management Inc. ($517.65K), Kathleen S. Wright Associates Inc. ($42.55K), New York State Common Retirement Fund ($18.87K), and Citigroup Inc. ($7.52K). How much institutional buying is happening at Turnstone Biologics? Institutional investors have bought a total of 4,125,193 shares in the last 24 months. This purchase volume represents approximately $16.20M in transactions. Which Turnstone Biologics major shareholders have been selling company stock? The following institutional investors have sold Turnstone Biologics stock in the last 24 months: PFM Health Sciences LP ($891.40K), and Caas Capital Management LP ($30.68K). How much institutional selling is happening at Turnstone Biologics? Institutional investors have sold a total of 922,074 shares in the last 24 months. This volume of shares sold represents approximately $2.35M in transactions. Related Companies: Ikena Oncology Institutional Ownership Aligos Therapeutics Institutional Ownership Cidara Therapeutics Institutional Ownership Instil Bio Institutional Ownership AVROBIO Institutional Ownership Elutia Institutional Ownership Genenta Science Institutional Ownership Cognition Therapeutics Institutional Ownership Gritstone bio Institutional Ownership Passage Bio Institutional Ownership This page (NASDAQ:TSBX) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingCharles Payne’s Gift to Stock InvestorsUnstoppable ProsperityHe Is Giving Away BitcoinCrypto Swap ProfitsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithElon Musk Secret Crypto Plot ExposedCrypto 101 MediaThe AI stock to buy right nowStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Turnstone Biologics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
